Concepedia

Publication | Open Access

Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial

45

Citations

29

References

2023

Year

Abstract

This study was sponsored by Betta Pharmaceutical Co., Ltd.

References

YearCitations

Page 1